| Lisa S Callegari, MD | |
|
1959 Ne Pacific St, Seattle, WA 98195-0001 | |
| (206) 520-5000 | |
| Not Available |
| Full Name | Lisa S Callegari |
|---|---|
| Gender | Female |
| Speciality | Obstetrics & Gynecology |
| Location | 1959 Ne Pacific St, Seattle, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003980319 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207V00000X | Obstetrics & Gynecology | MD60208572 (Washington) | Primary |
| Entity Name | The Association Of University Physicians |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023041159 PECOS PAC ID: 0446162697 Enrollment ID: O20031105000244 |
News Archive
Rutgers researchers studying COVID-19 have created a new way to deliver DNA molecules into skin cells, using a suction technique similar to the ancient healing practice of cupping.
The Associated Press: The two chairman of President Obama's debt commission told the National Governors Association Sunday that Medicare, Medicaid and Social Security are sucking up the entire federal discretionary budget.
Researcher Professor Norman Maitland of the Yorkshire Cancer Research Laboratory at York University, feels that this technology could be at least ten times better than CT scanners at detecting tumors. He explained, "Cancers deep within the body are difficult to spot at an early stage and early diagnosis is critical for the successful treatment of any form of cancer.
The U.S. Food and Drug Administration today approved the first drug, Oxervate (cenegermin), for the treatment of neurotrophic keratitis, a rare disease affecting the cornea (the clear layer that covers the colored portion of the front of the eye).
› Verified 4 days ago
| Entity Name | Harborview Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568557312 PECOS PAC ID: 3971404716 Enrollment ID: O20040115000760 |
News Archive
Rutgers researchers studying COVID-19 have created a new way to deliver DNA molecules into skin cells, using a suction technique similar to the ancient healing practice of cupping.
The Associated Press: The two chairman of President Obama's debt commission told the National Governors Association Sunday that Medicare, Medicaid and Social Security are sucking up the entire federal discretionary budget.
Researcher Professor Norman Maitland of the Yorkshire Cancer Research Laboratory at York University, feels that this technology could be at least ten times better than CT scanners at detecting tumors. He explained, "Cancers deep within the body are difficult to spot at an early stage and early diagnosis is critical for the successful treatment of any form of cancer.
The U.S. Food and Drug Administration today approved the first drug, Oxervate (cenegermin), for the treatment of neurotrophic keratitis, a rare disease affecting the cornea (the clear layer that covers the colored portion of the front of the eye).
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Lisa S Callegari, MD Po Box 50095, Seattle, WA 98145-5095 Ph: () - | Lisa S Callegari, MD 1959 Ne Pacific St, Seattle, WA 98195-0001 Ph: (206) 520-5000 |
News Archive
Rutgers researchers studying COVID-19 have created a new way to deliver DNA molecules into skin cells, using a suction technique similar to the ancient healing practice of cupping.
The Associated Press: The two chairman of President Obama's debt commission told the National Governors Association Sunday that Medicare, Medicaid and Social Security are sucking up the entire federal discretionary budget.
Researcher Professor Norman Maitland of the Yorkshire Cancer Research Laboratory at York University, feels that this technology could be at least ten times better than CT scanners at detecting tumors. He explained, "Cancers deep within the body are difficult to spot at an early stage and early diagnosis is critical for the successful treatment of any form of cancer.
The U.S. Food and Drug Administration today approved the first drug, Oxervate (cenegermin), for the treatment of neurotrophic keratitis, a rare disease affecting the cornea (the clear layer that covers the colored portion of the front of the eye).
› Verified 4 days ago
Dr. Jaime Marie Michaelson, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 310 15th Ave E, Seattle, WA 98112 Phone: 206-326-3000 | |
Alisa Beth Kachikis, M.D. Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1959 Ne Pacific St, 3rd Floor Sw 350, Seattle, WA 98195 Phone: 206-598-4070 | |
Karen L. Bohmke, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1101 Madison St, #1150, Seattle, WA 98104 Phone: 206-386-3400 | |
Anne-marie Elizabeth Amies Oelschlager, Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: Uwmc-roosevelt, 4245 Roosevelt Way Ne, Seattle, WA 98105 Phone: 206-598-5500 | |
Shirley Andrews, MD Obstetrics & Gynecology Medicare: Medicare Enrolled Practice Location: 1560 N 115th St Ste 212, Seattle, WA 98133 Phone: 206-363-2800 Fax: 206-363-2811 | |
Lyndsey Summer Benson, M.D. Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 1959 Ne Pacific St, Box 356460, Seattle, WA 98195 Phone: 610-202-4028 |